Site Search

Displaying results 61 - 69 of 69

CANCER-ID

Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood

ROADMAP

Real world outcomes across the AD spectrum for better care: multi-modal data access platform

Closed IMI2 Neurodegenerative diseases Alzheimer's disease BD4BO Big data and knowledge management Real-world data, evidence

WEB-RADR 2

Closed IMI2 Tools for predicting/monitoring safety Big data and knowledge management Real-world data, evidence Regulatory and HTA processes Methods for benefit/risk assessment

All the health innovation in the world is useless if it cannot be effectively integrated into the healthcare system. Image credit: Berit Kessler

01/07/2025

How health economics can press pause on Alzheimer’s disease

PROMINENT and AD-RIDDLE, two projects focusing on Alzheimer’s disease, are channelling health economics to ensure that new therapies and diagnostic methods for Alzheimer’s disease...

Impact on: clinical trials

The way that we carry out clinical trials can be improved, and IMI is funding a variety of projects that seek to optimise the process.

A heart within a wall of data. Image by ImageFlow via Shutterstock

28/09/2023

Research shows the hidden biases in cardiovascular disease data

BigData@Heart findings underscore importance of accounting for sex-based differences in medical research

EU-AIMS

European Autism Interventions - a Multicentre Study for Developing New Medications

Closed IMI1 Psychiatric diseases Autism Tools for predicting/monitoring safety Clinical trial design Stem cells Drug discovery

Impact on: Mental Health Disorders

IHI and IMI projects are shedding light on the biological basis of mental health disorders and finding new ways to diagnose, monitor and treat these conditions.

MOPEAD

Models of patient engagement for Alzheimer’s disease

Closed IMI2 Neurodegenerative diseases Alzheimer's disease Patient involvement in R&D